Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial by Scott Russell, Donoghoe Mark, Watts Gerald F, O'Brien Richard, Pardy Christopher, Taskinen Marja-Riitta, Davis Timothy ME, Colman Peter G, Manning Patrick, Fulcher Gregory, Keech Anthony C

Get full text